Editorial commentary: Understanding the cardiovascular benefits of glucagon-like peptide-1 (GLP-1) receptor agonists.
Saved in:
| Title: | Editorial commentary: Understanding the cardiovascular benefits of glucagon-like peptide-1 (GLP-1) receptor agonists. |
|---|---|
| Authors: | Raven LM; Department of Diabetes and Endocrinology, St Vincent's Hospital, Sydney, Australia; Clinical Diabetes, Appetite and Metabolism Laboratory, Garvan Institute of Medical Research, Sydney, Australia; School of Clinical Medicine, St Vincent's Campus, Faculty of Medicine and Health, University of New South Wales, Sydney, Australia. Electronic address: l.raven@garvan.org.au. |
| Source: | Trends in cardiovascular medicine [Trends Cardiovasc Med] 2024 Nov; Vol. 34 (8), pp. 558-559. Date of Electronic Publication: 2024 Mar 27. |
| Publication Type: | Editorial |
| Journal Info: | Publisher: Elsevier Science Publishing Country of Publication: United States NLM ID: 9108337 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2615 (Electronic) Linking ISSN: 10501738 NLM ISO Abbreviation: Trends Cardiovasc Med Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| ISSN: | 1873-2615 |
|---|---|
| DOI: | 10.1016/j.tcm.2024.03.007 |
